Diagnosis of human respiratory syncytial virus infection using reverse transcription loop-mediated isothermal amplification

被引:45
作者
Shirato, Kazuya
Nishimura, Hidekazu
Saijo, Masayuki
Okamoto, Michiko
Noda, Masahiro
Tashiro, Masato
Taguchi, Fumihiro
机构
[1] Natl Inst Infect Dis, Dept Virol 3, Lab Acute Resp Viral Dis & Cytokines, Murayama Branch, Tokyo 2080011, Japan
[2] Natl Inst Infect Dis, Dept Virol 1, Special Pathogen Lab, Tokyo 2080011, Japan
[3] Sendai Med Ctr, Virus Res Ctr, Miyagi 9838520, Japan
关键词
respiratory syncytial virus; RT-LAMP;
D O I
10.1016/j.jviromet.2006.09.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human respiratory syncytial virus (RSV) is a major causative agent of lower respiratory tract infections in children and the elderly. A reverse transcription-loop-mediated isothermal amplification (RT-LAMP) was developed assay to amplify the genome of RSV subgroups A and B, in order to improve current diagnostic methods for RSV infection. The primer sets for RT-LAMP were designed using highly conserved nucleotide sequences in the matrix protein region of subgroups A and B, and were specific for each subgroup. The RT-LAMP efficiency was compared to virus isolation and a commercially available enzyme immunoassay (EIA) for RSV detection (BD Directigen EZ RSV test (TM)), using nasopharyngeal aspirates from 59 children with respiratory tract infections. The RT-LAMP was specific for RSV and could not detect other respiratory pathogens. 61% (36/59) of children were positive by RT-LAMP, 34% (20/59) by viral isolation, and 56% (26/46) by EZ RSV. Of 16 specimens that were negative by both antigen detection and virus isolation, 12.5% (2/16) were RT-LAMP positive. These results suggest that the RT-LAMP is more sensitive than other methods used to detect RSV. The RT-LAMP assay developed in this study may be useful for diagnostic and epidemiological studies of RSV infection. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 29 条
  • [1] Abramson JS, 2003, PEDIATRICS, V112, P1442
  • [2] Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults
    Casiano-Colón, AE
    Hulbert, BB
    Mayer, TK
    Walsh, EE
    Falsey, AR
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 28 (02) : 169 - 174
  • [3] Test characteristics of the respiratory syncytial virus enzyme-linked immunoabsorbent assay in febrile infants ≤ 60 days of age
    Dayan, P
    Ahmad, F
    Urtecho, J
    Novick, M
    Dixon, P
    Levine, D
    Miller, S
    [J]. CLINICAL PEDIATRICS, 2002, 41 (06) : 415 - 418
  • [4] RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN IMMUNOCOMPROMISED ADULTS
    ENGLUND, JA
    SULLIVAN, CJ
    JORDAN, MC
    DEHNER, LP
    VERCELLOTTI, GM
    BALFOUR, HH
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 109 (03) : 203 - 208
  • [5] Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding
    Falsey, AR
    Formica, MA
    Treanor, JJ
    Walsh, EE
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (09) : 4160 - 4165
  • [6] Diagnosis of respiratory syncytial virus infection: Comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness
    Falsey, AR
    Formica, MA
    Walsh, EE
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 817 - 820
  • [7] Respiratory syncytial virus infection in adults
    Falsey, AR
    Walsh, EE
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) : 371 - +
  • [8] Diagnosis of viral respiratory tract infections in children using a reverse transcription-PCR panel
    Gilbert, LL
    Dakhama, A
    Bone, BM
    Thomas, EE
    Hegele, RG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (01) : 140 - 143
  • [9] ANTIGENIC VARIATION BETWEEN HUMAN RESPIRATORY SYNCYTIAL VIRUS ISOLATES
    GIMENEZ, HB
    HARDMAN, N
    KEIR, HM
    CASH, P
    [J]. JOURNAL OF GENERAL VIROLOGY, 1986, 67 : 863 - 870
  • [10] A review of vaccine research and development: Human acute respiratory infections
    Girard, MP
    Cherian, T
    Pervikov, Y
    Kieny, MP
    [J]. VACCINE, 2005, 23 (50) : 5708 - 5724